PT1334721E - Preparações de fármacos hidrofílicos contendo nateglinida - Google Patents
Preparações de fármacos hidrofílicos contendo nateglinida Download PDFInfo
- Publication number
- PT1334721E PT1334721E PT01976818T PT01976818T PT1334721E PT 1334721 E PT1334721 E PT 1334721E PT 01976818 T PT01976818 T PT 01976818T PT 01976818 T PT01976818 T PT 01976818T PT 1334721 E PT1334721 E PT 1334721E
- Authority
- PT
- Portugal
- Prior art keywords
- nateglinide
- preparation
- containing hydrophilic
- hydrophilic drug
- drug preparations
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- OELFLUMRDSZNSF-BRWVUGGUSA-N nateglinide Chemical compound C1C[C@@H](C(C)C)CC[C@@H]1C(=O)N[C@@H](C(O)=O)CC1=CC=CC=C1 OELFLUMRDSZNSF-BRWVUGGUSA-N 0.000 title abstract 3
- 229960000698 nateglinide Drugs 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000013078 crystal Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000324374 | 2000-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1334721E true PT1334721E (pt) | 2009-06-01 |
Family
ID=18801919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01976818T PT1334721E (pt) | 2000-10-24 | 2001-10-23 | Preparações de fármacos hidrofílicos contendo nateglinida |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040029968A1 (pt) |
| EP (1) | EP1334721B1 (pt) |
| JP (3) | JPWO2002040010A1 (pt) |
| KR (1) | KR100829410B1 (pt) |
| CN (1) | CN100531730C (pt) |
| AT (1) | ATE429217T1 (pt) |
| AU (1) | AU2001296000A1 (pt) |
| BR (1) | BR0114897A (pt) |
| CA (1) | CA2426764C (pt) |
| CY (1) | CY1110320T1 (pt) |
| DE (1) | DE60138476D1 (pt) |
| DK (1) | DK1334721T3 (pt) |
| ES (1) | ES2321911T3 (pt) |
| MX (1) | MXPA03003686A (pt) |
| PT (1) | PT1334721E (pt) |
| RU (1) | RU2283104C2 (pt) |
| SI (1) | SI1334721T1 (pt) |
| TW (1) | TWI289461B (pt) |
| WO (1) | WO2002040010A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02006443A (es) * | 1999-12-28 | 2002-11-29 | Ajinomoto Kk | Preparaciones orales para diabetes. |
| JP4501054B2 (ja) * | 2000-10-24 | 2010-07-14 | 味の素株式会社 | ナテグリニド含有製剤 |
| US6861553B2 (en) | 2002-07-03 | 2005-03-01 | Teva Pharmaceuticals Industries Ltd. | Process for preparing nateglinide and intermediates thereof |
| US7358390B2 (en) | 2002-07-18 | 2008-04-15 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
| US7420084B2 (en) | 2002-07-18 | 2008-09-02 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
| US7148376B2 (en) | 2002-07-18 | 2006-12-12 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of nateglinide |
| US7534913B2 (en) | 2002-07-18 | 2009-05-19 | Teva Pharmaceutica Industries Ltd. | Crystalline form of nateglinide |
| JP4505859B2 (ja) * | 2003-08-08 | 2010-07-21 | 味の素株式会社 | ナテグリニド含有製剤 |
| WO2005020979A1 (en) * | 2003-09-03 | 2005-03-10 | Ranbaxy Laboratories Limited | A process for the preparation of pharmaceutical compositions of nateglinide |
| US20070219250A1 (en) * | 2003-11-28 | 2007-09-20 | Romi Singh | Pharmaceutical Compositions of Nateglinide |
| WO2005092319A1 (en) * | 2004-03-29 | 2005-10-06 | Ranbaxy Laboratories Limited | Rapidly disintegrating pharmaceutical compositions comprising nateglinide and a disintegrant |
| WO2005094812A1 (ja) * | 2004-04-01 | 2005-10-13 | Ajinomoto Co., Inc. | ナテグリニド含有製剤 |
| US8586081B2 (en) * | 2007-09-20 | 2013-11-19 | University Of Massachusetts | Detoxified recombinant botulinum neurotoxin |
| WO2013066278A1 (en) * | 2011-11-03 | 2013-05-10 | Mahmut Bilgic | A process for production of pharmaceutical formulations comprising nateglinide |
| WO2013115739A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Production method for formulations comprising comprising nateglinide and lipoic acid |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH066532B2 (ja) * | 1983-09-29 | 1994-01-26 | 日産化学工業株式会社 | 親水性コロイドにより変性したワックス性微粉末 |
| JPS6354321A (ja) * | 1985-03-27 | 1988-03-08 | Ajinomoto Co Inc | 血糖降下剤 |
| US5474989A (en) * | 1988-11-11 | 1995-12-12 | Kurita Water Industries, Ltd. | Drug composition |
| US5463116A (en) * | 1991-07-30 | 1995-10-31 | Ajinomoto Co., Inc. | Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them |
| DE10199058I2 (de) * | 1991-07-30 | 2006-04-27 | Alcm Co | Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung |
| JPH0696517B2 (ja) * | 1993-03-17 | 1994-11-30 | 日産化学工業株式会社 | 変性したワックス性微粉末で被覆された薬剤及びその製造法 |
| JP2994956B2 (ja) * | 1994-05-31 | 1999-12-27 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロース、その組成物およびその錠剤 |
| DK1586314T3 (da) * | 1996-11-15 | 2011-06-20 | Ajinomoto Kk | Nateglinide tablet sammensætning |
| CA2216215A1 (en) * | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
| JP3591801B2 (ja) * | 1997-06-19 | 2004-11-24 | 田辺製薬株式会社 | 口腔内速崩壊性製剤の製法 |
| JP2000178183A (ja) * | 1998-12-17 | 2000-06-27 | Lion Corp | 固形製剤及びその製造方法 |
| JP2000290171A (ja) * | 1999-04-06 | 2000-10-17 | Eisai Co Ltd | 崩壊のはやい錠剤又はその製造方法 |
| MXPA02006443A (es) * | 1999-12-28 | 2002-11-29 | Ajinomoto Kk | Preparaciones orales para diabetes. |
| AU2001241168B2 (en) * | 2000-03-17 | 2005-06-16 | Ajinomoto Co., Inc. | Drugs for complications of diabetes and neuropathy and utilization thereof |
| CA2425533C (en) * | 2000-10-18 | 2010-04-20 | Ajinomoto Co., Inc. | Methods for producing acylphenylalanine |
| WO2002032854A1 (fr) * | 2000-10-18 | 2002-04-25 | Ajinomoto Co.,Inc. | Procede de production de cristaux de nateglinide |
| RU2275354C2 (ru) * | 2000-10-24 | 2006-04-27 | Адзиномото Ко., Инк. | Способы получения кристаллов в-типа натеглинида |
| JP4501054B2 (ja) * | 2000-10-24 | 2010-07-14 | 味の素株式会社 | ナテグリニド含有製剤 |
| US6830759B2 (en) * | 2002-06-28 | 2004-12-14 | Ajinomoto Co., Inc. | Antidiabetic preparation for oral administration |
-
2001
- 2001-10-23 PT PT01976818T patent/PT1334721E/pt unknown
- 2001-10-23 JP JP2002542384A patent/JPWO2002040010A1/ja active Pending
- 2001-10-23 ES ES01976818T patent/ES2321911T3/es not_active Expired - Lifetime
- 2001-10-23 SI SI200130912T patent/SI1334721T1/sl unknown
- 2001-10-23 TW TW090126184A patent/TWI289461B/zh not_active IP Right Cessation
- 2001-10-23 CN CNB018212182A patent/CN100531730C/zh not_active Expired - Fee Related
- 2001-10-23 BR BR0114897-4A patent/BR0114897A/pt not_active IP Right Cessation
- 2001-10-23 EP EP01976818A patent/EP1334721B1/en not_active Expired - Lifetime
- 2001-10-23 AU AU2001296000A patent/AU2001296000A1/en not_active Abandoned
- 2001-10-23 KR KR1020037005635A patent/KR100829410B1/ko not_active IP Right Cessation
- 2001-10-23 DK DK01976818T patent/DK1334721T3/da active
- 2001-10-23 MX MXPA03003686A patent/MXPA03003686A/es active IP Right Grant
- 2001-10-23 AT AT01976818T patent/ATE429217T1/de active
- 2001-10-23 CA CA2426764A patent/CA2426764C/en not_active Expired - Fee Related
- 2001-10-23 DE DE60138476T patent/DE60138476D1/de not_active Expired - Lifetime
- 2001-10-23 RU RU2003111949/15A patent/RU2283104C2/ru not_active IP Right Cessation
- 2001-10-23 WO PCT/JP2001/009292 patent/WO2002040010A1/ja active Application Filing
-
2003
- 2003-04-23 US US10/420,886 patent/US20040029968A1/en not_active Abandoned
-
2009
- 2009-06-11 CY CY20091100623T patent/CY1110320T1/el unknown
-
2010
- 2010-02-04 JP JP2010023025A patent/JP5278708B2/ja not_active Expired - Fee Related
-
2013
- 2013-01-11 JP JP2013003337A patent/JP5673972B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2321911T3 (es) | 2009-06-15 |
| EP1334721A1 (en) | 2003-08-13 |
| CA2426764C (en) | 2010-04-20 |
| MXPA03003686A (es) | 2004-01-26 |
| BR0114897A (pt) | 2003-08-12 |
| CN100531730C (zh) | 2009-08-26 |
| WO2002040010A1 (fr) | 2002-05-23 |
| JPWO2002040010A1 (ja) | 2004-06-03 |
| DE60138476D1 (de) | 2009-06-04 |
| SI1334721T1 (sl) | 2009-08-31 |
| ATE429217T1 (de) | 2009-05-15 |
| JP2013064018A (ja) | 2013-04-11 |
| CA2426764A1 (en) | 2003-04-23 |
| JP5673972B2 (ja) | 2015-02-18 |
| CN1482904A (zh) | 2004-03-17 |
| RU2283104C2 (ru) | 2006-09-10 |
| DK1334721T3 (da) | 2009-07-06 |
| US20040029968A1 (en) | 2004-02-12 |
| JP2010095551A (ja) | 2010-04-30 |
| TWI289461B (en) | 2007-11-11 |
| EP1334721B1 (en) | 2009-04-22 |
| EP1334721A4 (en) | 2005-11-02 |
| AU2001296000A1 (en) | 2002-05-27 |
| KR20030042028A (ko) | 2003-05-27 |
| CY1110320T1 (el) | 2015-01-14 |
| JP5278708B2 (ja) | 2013-09-04 |
| KR100829410B1 (ko) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110320T1 (el) | Παρασκευασματα υδροφιλου φαρμακου περιεχοντα νατεγλινιδη (nateglinide) | |
| ES2528359T3 (es) | Procedimiento para la producción de una forma medicamentosa oral con desintegración y puesta en libertad inmediatas de las sustancias activas | |
| KR100890180B1 (ko) | 경구투여제 및 경구투여제 유지체 | |
| BR9908121A (pt) | Forma galênica de liberação imediata e de liberação prolongada administrável por via oral compreendendo um agente estimulador de absorção e utilização deste agente estimulador de absorção | |
| ES2402544T3 (es) | Preparación pelicular rápidamente soluble | |
| ES2403069T3 (es) | Composición oral de liberación controlada que contiene levetiracetam | |
| CA2416869A1 (en) | Vaccines | |
| WO2002045684A3 (en) | Rapidly dispersing pharmaceutical composition comprising effervescent agents | |
| CA2338031A1 (en) | Biodegradable compositions for the controlled release of encapsulated substances | |
| AR029716A1 (es) | Productos dermatologicos en forma de hoja | |
| AU1301199A (en) | Drug delivery systems utilizing liquid crystal structures | |
| CA2288143A1 (en) | Activated protein c formulations | |
| EP1243269A3 (en) | Opioid formulations having extended controlled release | |
| BR9609663A (pt) | Formulações para desprendimento controlado de medicamentos fracamente soluveis | |
| RU2000123567A (ru) | Фармацевтическая композиция, содержащая в комбинации метформин и фибрат, и ее применение при приготовлении лекарственных средств, предназначенных для снижения гипергликемии | |
| CA2015536A1 (en) | Pharmaceutical formulation | |
| BE899635A (fr) | Compositions pharmaceutiques. | |
| KR101489524B1 (ko) | 발포성 보습 조성물 | |
| CA2419993A1 (en) | Process for preparing pharmaceutical compositions for use with soft gelatin formulations | |
| CA2403345A1 (en) | System for the controlled delivery of an active material to a dental site | |
| CA2215327A1 (en) | Formulations for lipophilic compounds | |
| EP0350701A3 (en) | Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes | |
| JP2006527008A (ja) | 超音波導入スキンケアデバイス | |
| JP3064417B2 (ja) | 放出制御性製剤及び方法 | |
| US20030064101A1 (en) | Floating osmotic device for controlled release drug delivery |